124 related articles for article (PubMed ID: 15857126)
21. Syntheses and ligand-binding studies of 1 alpha- and 17 alpha-aminoalkyl dihydrotestosterone derivatives to human sex hormone-binding globulin.
Hauptmann H; Metzger J; Schnitzbauer A; Cuilleron CY; Mappus E; Luppa PB
Steroids; 2003 Sep; 68(7-8):629-39. PubMed ID: 12957668
[TBL] [Abstract][Full Text] [Related]
22. Interaction of lignans with human sex hormone binding globulin (SHBG).
Schöttner M; Gansser D; Spiteller G
Z Naturforsch C J Biosci; 1997; 52(11-12):834-43. PubMed ID: 9463941
[TBL] [Abstract][Full Text] [Related]
23. Binding analysis of 1alpha- and 17alpha-dihydrotestosterone derivatives to homodimeric sex hormone-binding globulin.
Metzger J; Schnitzbauer A; Meyer M; Söder M; Cuilleron CY; Hauptmann H; Huber E; Luppa PB
Biochemistry; 2003 Nov; 42(46):13735-45. PubMed ID: 14622020
[TBL] [Abstract][Full Text] [Related]
24. Development of classification model and QSAR model for predicting binding affinity of endocrine disrupting chemicals to human sex hormone-binding globulin.
Liu H; Yang X; Lu R
Chemosphere; 2016 Aug; 156():1-7. PubMed ID: 27156209
[TBL] [Abstract][Full Text] [Related]
25. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
26. Estetrol does not bind sex hormone binding globulin or increase its production by human HepG2 cells.
Hammond GL; Hogeveen KN; Visser M; Coelingh Bennink HJ
Climacteric; 2008; 11 Suppl 1():41-6. PubMed ID: 18464022
[TBL] [Abstract][Full Text] [Related]
27. In silico studies and fluorescence binding assays of potential anti-prion compounds reveal an important binding site for prion inhibition from PrP(C) to PrP(Sc).
Pagadala NS; Perez-Pineiro R; Wishart DS; Tuszynski JA
Eur J Med Chem; 2015 Feb; 91():118-31. PubMed ID: 25042003
[TBL] [Abstract][Full Text] [Related]
28. QSAR based docking studies of marine algal anticancer compounds as inhibitors of protein kinase B (PKBβ).
Davis GD; Vasanthi AH
Eur J Pharm Sci; 2015 Aug; 76():110-8. PubMed ID: 25936945
[TBL] [Abstract][Full Text] [Related]
29. Crystal structure of human sex hormone-binding globulin in complex with 2-methoxyestradiol reveals the molecular basis for high affinity interactions with C-2 derivatives of estradiol.
Avvakumov GV; Grishkovskaya I; Muller YA; Hammond GL
J Biol Chem; 2002 Nov; 277(47):45219-25. PubMed ID: 12228253
[TBL] [Abstract][Full Text] [Related]
30. Virtual screening for the identification of novel nonsteroidal glucocorticoid modulators.
Onnis V; Kinsella GK; Carta G; Jagoe WN; Price T; Williams DC; Fayne D; Lloyd DG
J Med Chem; 2010 Apr; 53(8):3065-74. PubMed ID: 20334371
[TBL] [Abstract][Full Text] [Related]
31. Sex hormone-binding globulin in fish gills is a portal for sex steroids breached by xenobiotics.
Miguel-Queralt S; Hammond GL
Endocrinology; 2008 Sep; 149(9):4269-75. PubMed ID: 18483148
[TBL] [Abstract][Full Text] [Related]
32. Steroid-binding and dimerization domains of human sex hormone-binding globulin partially overlap: steroids and Ca2+ stabilize dimer formation.
Bocchinfuso WP; Hammond GL
Biochemistry; 1994 Sep; 33(35):10622-9. PubMed ID: 8075062
[TBL] [Abstract][Full Text] [Related]
33. Using molecular docking, 3D-QSAR, and cluster analysis for screening structurally diverse data sets of pharmacological interest.
Santos-Filho OA; Cherkasov A
J Chem Inf Model; 2008 Oct; 48(10):2054-65. PubMed ID: 18816024
[TBL] [Abstract][Full Text] [Related]
34. Molecular interactions of chlorpyrifos and its environmental degradation products with human sex hormone-binding globulin: an in silico study.
Hazarika J; Ganguly M; Mahanta R
J Appl Toxicol; 2019 Jul; 39(7):1002-1011. PubMed ID: 30815923
[TBL] [Abstract][Full Text] [Related]
35. Resolution of the human sex hormone-binding globulin dimer interface and evidence for two steroid-binding sites per homodimer.
Avvakumov GV; Grishkovskaya I; Muller YA; Hammond GL
J Biol Chem; 2001 Sep; 276(37):34453-7. PubMed ID: 11457864
[TBL] [Abstract][Full Text] [Related]
36. Stepwise development of structure-activity relationship of diverse PARP-1 inhibitors through comparative and validated in silico modeling techniques and molecular dynamics simulation.
Halder AK; Saha A; Saha KD; Jha T
J Biomol Struct Dyn; 2015; 33(8):1756-79. PubMed ID: 25350685
[TBL] [Abstract][Full Text] [Related]
37. Ligand biological activity predictions using fingerprint-based artificial neural networks (FANN-QSAR).
Myint KZ; Xie XQ
Methods Mol Biol; 2015; 1260():149-64. PubMed ID: 25502380
[TBL] [Abstract][Full Text] [Related]
38. Steroid binding properties of the 2nd WHO International Standard for sex hormone-binding globulin.
Thaler M; Müller C; Schlichtiger A; Gründler K; Moore M; Luppa PB
Clin Chem Lab Med; 2011 May; 49(5):869-72. PubMed ID: 21345159
[TBL] [Abstract][Full Text] [Related]
39. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
[TBL] [Abstract][Full Text] [Related]
40. Structure-based quantitative structure--activity relationship modeling of estrogen receptor β-ligands.
Dong X; Hilliard SG; Zheng W
Future Med Chem; 2011 Jun; 3(8):933-45. PubMed ID: 21707397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
